Immune Pharmaceuticals (IMNP) Posts Quarterly Earnings, Misses Expectations By $0.06 EPS
Immune Pharmaceuticals (NASDAQ:IMNP) issued its quarterly earnings data on Friday. The company reported ($0.27) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.21) by $0.06, AmericanBankingNews.com reports.
Immune Pharmaceuticals (NASDAQ:IMNP) opened at 4.00 on Friday. Immune Pharmaceuticals has a 1-year low of $1.15 and a 1-year high of $5.65. The stock’s 50-day moving average is $3.44 and its 200-day moving average is $3.49. The company’s market cap is $57.7 million.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.